Hua Medicine Stock Performance
| HUMDF Stock | USD 0.41 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hua Medicine are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Hua Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Hua Medicine is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1 B | |
| Total Cashflows From Investing Activities | -68.2 M |
Hua |
Hua Medicine Relative Risk vs. Return Landscape
If you would invest 41.00 in Hua Medicine on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Hua Medicine or generate 0.0% return on investment over 90 days. Hua Medicine is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Hua, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hua Medicine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hua Medicine's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Hua Medicine, and traders can use it to determine the average amount a Hua Medicine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HUMDF |
Based on monthly moving average Hua Medicine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hua Medicine by adding Hua Medicine to a well-diversified portfolio.
Hua Medicine Fundamentals Growth
Hua Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Hua Medicine, and Hua Medicine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hua Pink Sheet performance.
| Return On Equity | -0.55 | |||
| Return On Asset | -0.19 | |||
| Operating Margin | (11.95) % | |||
| Current Valuation | 418.87 M | |||
| Shares Outstanding | 966.57 M | |||
| Price To Book | 6.51 X | |||
| Price To Sales | 21.02 X | |||
| EBITDA | (321.78 M) | |||
| Cash And Equivalents | 675.24 M | |||
| Cash Per Share | 0.70 X | |||
| Total Debt | 71.53 M | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | 0.38 X | |||
| Cash Flow From Operations | (272.98 M) | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 903.55 M | |||
About Hua Medicine Performance
By analyzing Hua Medicine's fundamental ratios, stakeholders can gain valuable insights into Hua Medicine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hua Medicine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hua Medicine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hua Medicine Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. The company was incorporated in 2011 and is based in Beijing, China. Hua Medicine is traded on OTC Exchange in the United States.Things to note about Hua Medicine performance evaluation
Checking the ongoing alerts about Hua Medicine for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Hua Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hua Medicine generated a negative expected return over the last 90 days | |
| Hua Medicine has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (325.73 M) with profit before overhead, payroll, taxes, and interest of 6.49 M. | |
| Hua Medicine has accumulated about 675.24 M in cash with (272.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 16.0% of the company shares are held by company insiders |
- Analyzing Hua Medicine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hua Medicine's stock is overvalued or undervalued compared to its peers.
- Examining Hua Medicine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hua Medicine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hua Medicine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hua Medicine's pink sheet. These opinions can provide insight into Hua Medicine's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Hua Pink Sheet analysis
When running Hua Medicine's price analysis, check to measure Hua Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hua Medicine is operating at the current time. Most of Hua Medicine's value examination focuses on studying past and present price action to predict the probability of Hua Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hua Medicine's price. Additionally, you may evaluate how the addition of Hua Medicine to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world |